Rakez Kayed

Dr. Rakez Kayed is the John Sealy Distinguished Chair in Parkinson’s Disease Research, Professor at the Departments of Neurology and Neuroscience & Cell Biology & Anatomy, and a member of George & Cynthia Mitchell Center for Neurodegenerative Diseases at University of Texas Medical Branch, Galveston Texas. A world-class expert of amyloid-beta (Aβ), tau oligomers, and tau oligomer specific antibodies. Dr. Kayed has 16 years of experience in the study of Aβ and tau oligomers and their role in disease. He made enormous contributions to the Aβ and tau fields of Alzheimer’s disease (AD) research. Some of his and his team discoveries in this field, as well as the development of novel methods and reagents, have allowed other researchers around the world to greatly advance the understanding of the mechanisms of neurodegenerative pathogenesis of AD and other neurological disorders of aging. He has an exceptionally vibrant track record for engaging in cutting-edge amyloid research, coauthoring more than 135 peer-reviewed articles with more than 27,000 citations. Dr. Kayed is a senior advisor of NeyroblastGX, closely working with the company’s team to generate next-generation theranostic products for AD.